You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

About the Ellipta device

The Ellipta is a multi-dose dry powder inhaler (DPI). Three different medicines for asthma and/or COPD are available using the Ellipta device. The inhaler is packaged within a moisture-protective foil tray with a desiccant and a peelable lid.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed on this website or in the product package leaflet. You can also report side effects directly to the HPRA Pharmacovigilance, Earlsfort Terrace, Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; e-mail:medsafety@hpra.ie.

By reporting side effects you can help provide more information on the safety of this medicine.

Ellipta is a registered trademark of the GlaxoSmithKline group of companies.